Category: Clinical Trials

Nanostics is pleased to announce the launch of clinical validation study

June 6, 2019

EDMONTON, June 4, 2019 /CNW/ – Nanostics Inc. is pleased […]

Working to include Yukoners in APCaRI

November 27, 2018

APCaRI, represented by John Lewis and Catalina Vasquez, met with […]

Dr. Nawaid Usmani and team receive funding for their PRIME study!

April 15, 2016

The PRIME Study – Prevention and Intervention for MEtabolic syndrome: […]

The Calgary Prostate Cancer Centre has the highest accrual for a novel ultrasound study in prostate cancer

December 15, 2015

“We have enrolled over 400 patients at our site, reaching […]

The Alberta Prostate Cancer Biorepository is certified by CTRNet

December 9, 2015

APCaRI is committed to collecting, processing and storing the samples […]

15th Annual Personalized Medicine Conference

Conference speakers will be focused on science, business, and policy issues facing personalized medicine scientists as they augment their research with AI and advanced data analytics. Digital health applications are expanding. Personalized medicine is evolving. This new paradigm will empower physicians and patients with a data-rich, expanded set of ‘omic and microbiome biological characteristics.
What are the predicted results of this evolution? Access to increasingly impactful therapies for patients and their healthcare teams.
Rume will be attending this conference to listen to experts in the field of Personalized medicine and learn how they are approaching these issues and turning them into opportunities for APCaRI.

- Unknown